Доступ предоставлен для: Guest
Critical Reviews™ in Therapeutic Drug Carrier Systems
Главный редактор: Mandip Sachdeva Singh (open in a new tab)

Выходит 6 номеров в год

ISSN Печать: 0743-4863

ISSN Онлайн: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Psoriasis Clinical Implications and Treatment: A Review

Том 30, Выпуск 3, 2013, pp. 183-216
DOI: 10.1615/CritRevTherDrugCarrierSyst.2013005268
Get accessGet access

Краткое описание

Psoriasis is a common skin disorder affecting the population worldwide. It is a T-cell mediated autoimmune disorder leading to keratinocyte hyperproliferation. Psoriasis has genetic predisposition that is further aggravated by certain stimulating factors. In spite of significant advances in understanding the pathogenesis of psoriasis, the exact etiology of the disease remains unknown. The clinical manifestations of this disease include various forms that affect different parts of the body. Treatment options vary according to the mode of application or severity of the disease. Earlier treatments have included application of emollients or keratolytic agents to hydrate the skin or shed off the skin. But later treatments have been modified to treat the underlying T-cell proliferation. Hence, topical treatments like coal tar, vitamin D, retinoids, topical calcineurin inhibitors for treating mild psoriasis, systemic treatments including methotrexate, cyclosporine, acitretin, hydroxyurea, as well as light therapy for severe psoriasis have become more prominent. Current treatment modalities are associated with the risk of serious side effects from prolonged treatment. Combinations of these therapies have provided effective and rapid modalities to suppress the disease and reduce the side effects of treatment. In addition, newer carrier systems for conventional drugs are being developed to improve the effectiveness of treatment and reduce the side effects. Development of biologics and gene therapy have revolutionized the treatment of this skin disease. Although an array of therapies to suppress the psoriatic condition exists, none are curative.

ЦИТИРОВАНО В
  1. Raju T Shantha, Strohl William R, Potential therapeutic roles for antibody mixtures, Expert Opinion on Biological Therapy, 13, 10, 2013. Crossref

  2. Hayez Aurélie, Malaisse Jérémy, Roegiers Edith, Reynier Marie, Renard Chantal, Haftek Marek, Geenen Vincent, Serre Guy, Simon Michel, de Rouvroit Catherine Lambert, Michiels Carine, Poumay Yves, High TMEM45A expression is correlated to epidermal keratinization, Experimental Dermatology, 23, 5, 2014. Crossref

  3. Zhang Claire Shuiqing, Yu Jason Jingjie, Parker Shefton, Zhang Anthony Lin, May Brian, Lu Chuanjian, Xue Charlie Changli, Oral Chinese herbal medicine combined with pharmacotherapy for psoriasis vulgaris: a systematic review, International Journal of Dermatology, 53, 11, 2014. Crossref

  4. Törmä H., Bergström A., Ghiasifarahani G., Berne B., The effect of two endogenous retinoids on the mRNA expression profile in human primary keratinocytes, focusing on genes causing autosomal recessive congenital ichthyosis, Archives of Dermatological Research, 306, 8, 2014. Crossref

  5. Cordiali-Fei P., Bianchi L., Bonifati C., Trento E., Ruzzetti M., Francesconi F., Bultrini S., D’Agosto G., Bordignon V., Francavilla V., Tripiciano A., Chiricozzi A., Campione E., Cavallotti C., Orlandi A., Berardesca E., Di Carlo A., Chimenti S., Ensoli F., Immunologic Biomarkers for Clinical and Therapeutic Management of Psoriasis, Mediators of Inflammation, 2014, 2014. Crossref

  6. Boehncke Wolf-Henning, Schön Michael P, Psoriasis, The Lancet, 386, 9997, 2015. Crossref

  7. Brouwer Katrien M., Lundvig Ditte M. S., Middelkoop Esther, Wagener Frank A. D. T. G., Von den Hoff Johannes W., Mechanical cues in orofacial tissue engineering and regenerative medicine, Wound Repair and Regeneration, 23, 3, 2015. Crossref

  8. Vrolijk Misha F., Opperhuizen Antoon, Jansen Eugène H.J.M., Godschalk Roger W., Van Schooten Frederik J., Bast Aalt, Haenen Guido R.M.M., The shifting perception on antioxidants: The case of vitamin E and β-carotene, Redox Biology, 4, 2015. Crossref

  9. Jacobi Arnd, Mayer Anke, Augustin Matthias, Keratolytics and Emollients and Their Role in the Therapy of Psoriasis: a Systematic Review, Dermatology and Therapy, 5, 1, 2015. Crossref

  10. Duan Lihua, Chen Liying, Zhong Shan, Wang Ying, Huang Yan, He Yan, Chen Jie, Shi Guixiu, Treatment of Bullous Systemic Lupus Erythematosus, Journal of Immunology Research, 2015, 2015. Crossref

  11. Zhang Claire Shuiqing, Yang Lihong, Zhang Anthony Lin, May Brian H., Yu Jason Jingjie, Guo Xinfeng, Lu Chuanjian, Xue Charlie Changli, Is Oral Chinese Herbal Medicine Beneficial for Psoriasis Vulgaris? A Meta-Analysis of Comparisons with Acitretin, The Journal of Alternative and Complementary Medicine, 22, 3, 2016. Crossref

  12. Marahatta Anu, Ware Russell E., Hydroxyurea: Analytical techniques and quantitative analysis, Blood Cells, Molecules, and Diseases, 67, 2017. Crossref

  13. Salem Samar Abdallah M., El-Khateeb Ekramy Ahmed, Harvy Mervat, Emam Hanaa Mohamed El-Sayed, Abdelaal Wafaa, Nemr Reham El, El-Hagry Omneya Osama, Study of serum levels and skin expression of S100B protein in psoriasis, Anais Brasileiros de Dermatologia, 92, 3, 2017. Crossref

  14. Mao Kai-Li, Fan Zi-Liang, Yuan Jian-Dong, Chen Pian-Pian, Yang Jing-Jing, Xu Jie, ZhuGe De-Li, Jin Bing-Hui, Zhu Qun-Yan, Shen Bi-Xin, Sohawon Yasin, Zhao Ying-Zheng, Xu He-Lin, Skin-penetrating polymeric nanoparticles incorporated in silk fibroin hydrogel for topical delivery of curcumin to improve its therapeutic effect on psoriasis mouse model, Colloids and Surfaces B: Biointerfaces, 160, 2017. Crossref

  15. Komiya Eriko, Hatano Ryo, Otsuka Haruna, Itoh Takumi, Yamazaki Hiroto, Yamada Taketo, Dang Nam H., Tominaga Mitsutoshi, Suga Yasushi, Kimura Utako, Takamori Kenji, Morimoto Chikao, Ohnuma Kei, A possible role for CD26/DPPIV enzyme activity in the regulation of psoriatic pruritus, Journal of Dermatological Science, 86, 3, 2017. Crossref

  16. Picciani Bruna Lavinas Sayed, Domingos Tábata Alves, Teixeira-Souza Thays, Santos Vanessa de Carla Batista dos, Gonzaga Heron Fernando de Sousa, Cardoso-Oliveira Juliana, Gripp Alexandre Carlos, Dias Eliane Pedra, Carneiro Sueli, Geographic tongue and psoriasis: clinical, histopathological, immunohistochemical and genetic correlation - a literature review, Anais Brasileiros de Dermatologia, 91, 4, 2016. Crossref

  17. Jain Anjali, Pooladanda Venkatesh, Bulbake Upendra, Doppalapudi Sindhu, Rafeeqi Towseef Amin, Godugu Chandraiah, Khan Wahid, Liposphere mediated topical delivery of thymoquinone in the treatment of psoriasis, Nanomedicine: Nanotechnology, Biology and Medicine, 13, 7, 2017. Crossref

  18. Picciani Bruna, Santos Vanessa de Carla, Teixeira-Souza Thays, Izahias Lívia Maria, Curty Áquila, Avelleira João Carlos, Azulay David, Pinto Jane, Carneiro Sueli, Dias Eliane, Investigation of the clinical features of geographic tongue: unveiling its relationship with oral psoriasis, International Journal of Dermatology, 56, 4, 2017. Crossref

  19. Zhou H., Shi H.-J., Yang J., Chen W.-G., Xia L., Song H.-B., Bo K.-P., Ma W., Efficacy of oxymatrine for treatment and relapse suppression of severe plaque psoriasis: results from a single-blinded randomized controlled clinical trial, British Journal of Dermatology, 176, 6, 2017. Crossref

  20. Ogami M, Kulkarni R, Wang H, Reif R, Wang R K, Laser speckle contrast imaging of skin blood perfusion responses induced by laser coagulation, Quantum Electronics, 44, 8, 2014. Crossref

  21. Yu Xiao-Jing, Song Tie-Jun, Zhang Lu-Wei, Su Ying, Wang Ke-Yu, Sun Qing, TRB3 is elevated in psoriasis vulgaris lesions and mediates HaCaT cells proliferation in vitro, Journal of Investigative Medicine, 65, 7, 2017. Crossref

  22. Graziano Mario, Rossi Mauro, An update on the cutaneous manifestations of coeliac disease and non-coeliac gluten sensitivity, International Reviews of Immunology, 37, 6, 2018. Crossref

  23. Bressan Aline L., Picciani Bruna L. S., Azulay-Abulafia Luna, Fausto-Silva Anna K., Almeida Paula N., Cunha Karin S. G., Dias Eliane P., Carneiro Sueli, Evaluation of ICAM-1 expression and vascular changes in the skin of patients with plaque, pustular, and erythrodermic psoriasis, International Journal of Dermatology, 57, 2, 2018. Crossref

  24. Lai Rui, Xian Dehai, Xiong Xia, Yang Lingyu, Song Jing, Zhong Jianqiao, Proanthocyanidins: novel treatment for psoriasis that reduces oxidative stress and modulates Th17 and Treg cells, Redox Report, 23, 1, 2018. Crossref

  25. Chen Wangqing, Zhang Xu, Zhang Wei, Peng Cong, Zhu Wu, Chen Xiang, Polymorphisms of SLCO1B1 rs4149056 and SLC22A1 rs2282143 are associated with responsiveness to acitretin in psoriasis patients, Scientific Reports, 8, 1, 2018. Crossref

  26. Yang Jiaxing, Sun Liguang, Han Jun, Zheng Wei, Peng Weihai, DUSP1/MKP-1 regulates proliferation and apoptosis in keratinocytes through the ERK/Elk-1/Egr-1 signaling pathway, Life Sciences, 223, 2019. Crossref

  27. Negi Poonam, Sharma Ishita, Hemrajani Chetna, Rathore Charul, Bisht Alpna, Raza Kaisar, Katare O. P., Thymoquinone-loaded lipid vesicles: a promising nanomedicine for psoriasis, BMC Complementary and Alternative Medicine, 19, 1, 2019. Crossref

  28. Yi Fei, Zheng Xiaoli, Fang Fang, Zhang Jiaan, Zhou Bingrong, Chen Xiangsheng, ALA‐PDT alleviates the psoriasis by inhibiting JAK signalling pathway, Experimental Dermatology, 28, 11, 2019. Crossref

  29. Mombrini Pigatti Fernanda, de Freitas Bombarda-Nunes Fabiana, Fernandes Leal Lucas, Teixeira de Souza Thays, The Use of Phototherapy in Treatment of Geographic Tongue in Patients with Psoriasis, in Tailored Treatments in Psoriatic Patients, 2019. Crossref

  30. Ghate Vivek M., Kodoth Arun K., Shah Abhishek, Vishalakshi Badalamoole, Lewis Shaila A., Colloidal nanostructured lipid carriers of pentoxifylline produced by microwave irradiation ameliorates imiquimod-induced psoriasis in mice, Colloids and Surfaces B: Biointerfaces, 181, 2019. Crossref

  31. Wang Ailin, Wei Jianan, Lu Chuanjian, Chen Haiming, Zhong Xiaoqin, Lu Yue, Li Leng, Huang Haiding, Dai Zhenhua, Han Ling, Genistein suppresses psoriasis-related inflammation through a STAT3–NF-κB-dependent mechanism in keratinocytes, International Immunopharmacology, 69, 2019. Crossref

  32. Martínez-Ortega Leticia, Mira Amalia, Fernandez-Carvajal Asia, Mateo C. Reyes, Mallavia Ricardo, Falco Alberto, Development of A New Delivery System Based on Drug-Loadable Electrospun Nanofibers for Psoriasis Treatment, Pharmaceutics, 11, 1, 2019. Crossref

  33. Sharma Mandeep, Sharma Gajanand, Singh Bhupinder, Dhiman Vandana, Bhadada Sanjay Kumar, Katare O.P., Holistic development of coal tar lotion by embedding design of experiments (DoE) technique: preclinical investigations, Expert Opinion on Drug Delivery, 17, 2, 2020. Crossref

  34. Luan Chao, Chen Xu, Hu Yu, Hao Zhimin, Osland Jared M., Chen Xundi, Gerber Skyler D., Chen Min, Gu Heng, Yuan Rong, Overexpression and potential roles of NRIP1 in psoriasis, Oncotarget, 7, 45, 2016. Crossref

  35. Qadir Abdul, Aqil Mohd, Ali Athar, Ahmad Farhan J., Ahmad Sayeed, Beg Sarwar, Khan Nausheen, Comparative evaluation of the liquid chromatographic methods for simultaneous analysis of quercetin and salicin in an anti‐psoriasis polyherbal formulation, SEPARATION SCIENCE PLUS, 3, 4, 2020. Crossref

  36. Patak Jameson, Faraone Stephen V., Zhang‐James Yanli, Sodium hydrogen exchanger 9 NHE9 ( SLC9A9 ) and its emerging roles in neuropsychiatric comorbidity , American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 183, 5, 2020. Crossref

  37. Gao Lihua, Dou Jianhua, Zhang Bo, Zeng Jinrong, Cheng Qingmei, Lei Li, Tan Lina, Zeng Qinghai, Ding Shu, Guo Aiyuan, Cheng Haipeng, Yang Caifeng, Luo Ziqiang, Lu Jianyun, Ozone therapy promotes the differentiation of basal keratinocytes via increasing Tp63‐mediated transcription of KRT10 to improve psoriasis, Journal of Cellular and Molecular Medicine, 24, 8, 2020. Crossref

  38. Lu Yu-ting, Guan Rong, Zheng Jia-run, Hang Tai-jun, Song Min, Determination of clobetasol propionate, tazarotene and tazarotenic acid in Bama mini-pig skin by UPLC-MS/MS: Application to pharmacokinetic and drug-drug interaction studies, Journal of Pharmaceutical and Biomedical Analysis, 186, 2020. Crossref

  39. Qadir Abdul, Aqil Mohd, Ali Athar, Warsi Musarrat Husain, Mujeeb Mohd, Ahmad Farhan J., Ahmad Sayeed, Beg Sarwar, Nanostructured lipidic carriers for dual drug delivery in the management of psoriasis: Systematic optimization, dermatokinetic and preclinical evaluation, Journal of Drug Delivery Science and Technology, 57, 2020. Crossref

  40. Wang Haizhen, Zhang Yujin, Luomei Junzi, Huang Pan, Zhou Rong, Peng Youhua, The miR‐155/GATA3/IL37 axis modulates the production of proinflammatory cytokines upon TNF‐α stimulation to affect psoriasis development, Experimental Dermatology, 29, 7, 2020. Crossref

  41. Bakulev Andrey L., Krachevnya S. S, Igonina I. A, Galkina E. M, Utz S. R, PSORIASIS ADJUVANT THERAPY, Russian Journal of Skin and Venereal Diseases, 20, 6, 2017. Crossref

  42. Yang Zhibo, Chen Zhenping, Wang Chang, Huang Pan, Luo Meijunzi, Zhou Rong, STAT3/SH3PXD2A-AS1/miR-125b/STAT3 positive feedback loop affects psoriasis pathogenesis via regulating human keratinocyte proliferation, Cytokine, 144, 2021. Crossref

  43. Adil Sidra, Paracha Rehan Zafar, Tariq Salma, Nisar Maryum, Ijaz Sadaf, Siddiqa Amnah, Hussain Zamir, Amir Afreenish, A Computational Systems Analyses to Identify Biomarkers and Mechanistic Link in Psoriasis and Cutaneous Squamous Cell Carcinoma, Frontiers in Immunology, 12, 2021. Crossref

  44. Prieto-Pérez Rocío, Cabaleiro Teresa, Daudén Esteban, Ochoa Dolores, Román Manuel, Abad-Santos Francisco, Pharmacogenetics of topical and systemic treatment of psoriasis, Pharmacogenomics, 14, 13, 2013. Crossref

  45. Novikov Y.A., Zubareva E.Y., Kungurova L.R., Lekavichus I.Y., Maslova M.S., Zadorozhnaya A.V., Complex topical therapy of progressive psoriasis, Klinicheskaya dermatologiya i venerologiya, 21, 1, 2022. Crossref

  46. Лукьянов А.М., Topical Therapy for Psoriasis. Part II, Дерматовенерология Косметология, 4, 2021. Crossref

  47. Zhu Jiali, Yang Tao, Tang Minghai, Yang Zhuang, Pei Heying, Ye Haoyu, Tang Yu, Cheng Zhixuan, Lin Ping, Chen Lijuan, Studies on the anti-psoriasis effects and its mechanism of a dual JAK2/FLT3 inhibitor flonoltinib maleate, Biomedicine & Pharmacotherapy, 137, 2021. Crossref

  48. Shin Joo Eun, Lee Su Jin, Gharbi Amal, Jung In Duk, Park Yeong Min, IOX1 impedes host inflammation in imiquimod-triggered psoriasis, Heliyon, 7, 11, 2021. Crossref

  49. Bernardes Maria Tereza Carneiro Paschoal, Agostini Sandra Barbosa Neder, Pereira Gislaine Ribeiro, da Silva Laíla Pereira, da Silva Jéssica Bassi, Bruschi Marcos Luciano, Novaes Rômulo Dias, Carvalho Flávia Chiva, Preclinical study of methotrexate-based hydrogels versus surfactant based liquid crystal systems on psoriasis treatment, European Journal of Pharmaceutical Sciences, 165, 2021. Crossref

  50. Sharma Amit, Upadhyay Deepak Kumar, Gupta Ghanshyam Das, Narang Raj Kumar, Rai Vineet Kumar, IL-23/Th17 Axis: A Potential Therapeutic Target of Psoriasis, Current Drug Research Reviews, 14, 1, 2022. Crossref

  51. Ingram Michelle A., Jones M. Beatrix, Stonehouse Welma, Jarrett Paul, Scragg Robert, Mugridge Owen, von Hurst Pamela R., Oral vitamin D3 supplementation for chronic plaque psoriasis: a randomized, double-blind, placebo-controlled trial, Journal of Dermatological Treatment, 29, 7, 2018. Crossref

  52. Asimus Sara, Palmér Robert, Albayaty Muna, Forsman Henrik, Lundin Christina, Olsson Marita, Pehrson Rikard, Mo John, Russell Muir, Carlert Sara, Close David, Keeling David, Pharmacokinetics, pharmacodynamics and safety of the inverse retinoic acid‐related orphan receptor γ agonist AZD0284, British Journal of Clinical Pharmacology, 86, 7, 2020. Crossref

  53. Tanghetti Emil A., Stein Gold Linda, Del Rosso James Q., Lin Tina, Angel Arturo, Pillai Radhakrishnan, Optimized formulation for topical application of a fixed combination halobetasol/tazarotene lotion using polymeric emulsion technology, Journal of Dermatological Treatment, 32, 4, 2021. Crossref

  54. Jahan Afroz, Akhtar Juber, Badruddeen , Jaiswal Neha, Ali Asad, Ahmad Usama, Recapitulate genistein for topical applications including nanotechnology delivery, Inorganic and Nano-Metal Chemistry, 52, 9, 2022. Crossref

  55. Jales Silvana T. L., Barbosa Raquel de M., de Albuquerque André C., Duarte Luan H. V., da Silva Girliane R., Meirelles Lyghia M. A., da Silva Tania M. S., Alves Adriano F., Viseras César, Raffin Fernanda N., Moura Tulio F. A. de L., Development and Characterization of Aloe vera Mucilaginous-Based Hydrogels for Psoriasis Treatment, Journal of Composites Science, 6, 8, 2022. Crossref

  56. Marsili F., Travaglini M., Stinco G., Manzoni R., Tiberio R., Prignano F., Mazzotta A., Cannavò S. P., Cuccia A., Germino M., Bongiorno M. R., Persechino S., Florio T., Pettinato M., Tabanelli M., Sarkar R., Aloisi E., Bartezaghi M., Orsenigo R., Effectiveness of cyclosporine A in patients with moderate to severe plaque psoriasis in a real-life clinical setting in Italy: the TRANSITION study, Journal of Dermatological Treatment, 33, 1, 2022. Crossref

  57. Ehsan Muhammad, Rehman Aqeeb Ur, Athar Farwa, Mustafa Biah, Javed Haseeba, Cheema Huzaifa Ahmad, Ayyan Muhammad, Shahid Abia, Jafar Uzair, Goldust Mohamad, Benvitimod for the treatment of psoriasis: A systematic review and meta‐analysis of randomized controlled trials, Dermatologic Therapy, 35, 12, 2022. Crossref

Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции Цены и условия подписки Begell House Контакты Language English 中文 Русский Português German French Spain